M Elizabeth Hartnett1, Margaux A Morrison1, Silvia Smith1, Tammy L Yanovitch2, Terri L Young3, Tarah Colaizy4, Allison Momany4, John Dagle4, Waldemar A Carlo5, Erin A S Clark6, Grier Page7, Jeff Murray4, Margaret M DeAngelis1, C Michael Cotten8. 1. Department of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, Utah, United States. 2. Dean McGee Eye Center, University of Oklahoma, Oklahoma City, Oklahoma, United States. 3. Duke Eye Center, Duke University Medical Center, Durham, North Carolina, United States. 4. Department of Pediatrics, University of Iowa, Iowa City, Iowa, United States. 5. Department of Pediatrics, University of Alabama, Birmingham, Alabama, United States. 6. Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah, United States. 7. Research Triangle Park, Raleigh, North Carolina, United States. 8. Duke Eye Center, Duke University Medical Center, Durham, North Carolina, United States Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, United States.
Abstract
PURPOSE: To determine genetic variants associated with severe retinopathy of prematurity (ROP) in a candidate gene cohort study of US preterm infants. METHODS: Preterm infants in the discovery cohort were enrolled through the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network, and those in the replication cohort were from the University of Iowa. All infants were phenotyped for ROP severity. Because of differences in the durations of enrollment between cohorts, severe ROP was defined as threshold disease in the discovery cohort and as threshold disease or type 1 ROP in the replication cohort. Whole genome amplified DNA from stored blood spot samples from the Neonatal Research Network biorepository was genotyped using an Illumina GoldenGate platform for candidate gene single nucleotide polymorphisms (SNPs) involving angiogenic, developmental, inflammatory, and oxidative pathways. Three analyses were performed to determine significant epidemiologic variables and SNPs associated with levels of ROP severity. Analyses controlled for multiple comparisons, ancestral eigenvalues, family relatedness, and significant epidemiologic variables. Single nucleotide polymorphisms significantly associated with ROP severity from the discovery cohort were analyzed in the replication cohort and in meta-analysis. RESULTS: Eight hundred seventeen infants in the discovery cohort and 543 in the replication cohort were analyzed. Severe ROP occurred in 126 infants in the discovery and in 14 in the replication cohort. In both cohorts, ventilation days and seizure occurrence were associated with severe ROP. After controlling for significant factors and multiple comparisons, two intronic SNPs in the gene BDNF (rs7934165 and rs2049046, P < 3.1 × 10(-5)) were associated with severe ROP in the discovery cohort and were not associated with severe ROP in the replication cohort. However, when the cohorts were analyzed together in an exploratory meta-analysis, rs7934165 increased in associated significance with severe ROP (P = 2.9 × 10(-7)). CONCLUSIONS: Variants in BDNF encoding brain-derived neurotrophic factor were associated with severe ROP in a large candidate gene study of infants with threshold ROP. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE: To determine genetic variants associated with severe retinopathy of prematurity (ROP) in a candidate gene cohort study of US preterm infants. METHODS: Preterm infants in the discovery cohort were enrolled through the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network, and those in the replication cohort were from the University of Iowa. All infants were phenotyped for ROP severity. Because of differences in the durations of enrollment between cohorts, severe ROP was defined as threshold disease in the discovery cohort and as threshold disease or type 1 ROP in the replication cohort. Whole genome amplified DNA from stored blood spot samples from the Neonatal Research Network biorepository was genotyped using an Illumina GoldenGate platform for candidate gene single nucleotide polymorphisms (SNPs) involving angiogenic, developmental, inflammatory, and oxidative pathways. Three analyses were performed to determine significant epidemiologic variables and SNPs associated with levels of ROP severity. Analyses controlled for multiple comparisons, ancestral eigenvalues, family relatedness, and significant epidemiologic variables. Single nucleotide polymorphisms significantly associated with ROP severity from the discovery cohort were analyzed in the replication cohort and in meta-analysis. RESULTS: Eight hundred seventeen infants in the discovery cohort and 543 in the replication cohort were analyzed. Severe ROP occurred in 126 infants in the discovery and in 14 in the replication cohort. In both cohorts, ventilation days and seizure occurrence were associated with severe ROP. After controlling for significant factors and multiple comparisons, two intronic SNPs in the gene BDNF (rs7934165 and rs2049046, P < 3.1 × 10(-5)) were associated with severe ROP in the discovery cohort and were not associated with severe ROP in the replication cohort. However, when the cohorts were analyzed together in an exploratory meta-analysis, rs7934165 increased in associated significance with severe ROP (P = 2.9 × 10(-7)). CONCLUSIONS: Variants in BDNF encoding brain-derived neurotrophic factor were associated with severe ROP in a large candidate gene study of infants with threshold ROP. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Brian A Darlow; Jolie L Hutchinson; David J Henderson-Smart; Deborah A Donoghue; Judy M Simpson; Nicholas J Evans Journal: Pediatrics Date: 2005-04 Impact factor: 7.124
Authors: Ruslan N Grishanin; Haidong Yang; Xiaorong Liu; Kate Donohue-Rolfe; George C Nune; Keling Zang; Baoji Xu; Jacque L Duncan; Matthew M Lavail; David R Copenhagen; Louis F Reichardt Journal: Mol Cell Neurosci Date: 2008-04-22 Impact factor: 4.314
Authors: Anna Ells; Duane L Guernsey; Karin Wallace; Binyou Zheng; Michael Vincer; Alexander Allen; April Ingram; Orlando DaSilva; Lee Siebert; Thomas Sheidow; Jill Beis; Johane M Robitaille Journal: Ophthalmic Genet Date: 2010-03 Impact factor: 1.803
Authors: Waldemar A Carlo; Scott A McDonald; Jon E Tyson; Barbara J Stoll; Richard A Ehrenkranz; Seetha Shankaran; Ronald N Goldberg; Abhik Das; Diana Schendel; Poul Thorsen; Kristin Skogstrand; David M Hougaard; William Oh; Abbot R Laptook; Shahnaz Duara; Avroy A Fanaroff; Edward F Donovan; Sheldon B Korones; David K Stevenson; Lu-Ann Papile; Neil N Finer; T Michael O'Shea; Brenda B Poindexter; Linda L Wright; Namasivayam Ambalavanan; Rosemary D Higgins Journal: J Pediatr Date: 2011-07-27 Impact factor: 4.406
Authors: John M Dagle; Kelli K Ryckman; Cassandra N Spracklen; Allison M Momany; C Michael Cotten; Joshua Levy; Grier P Page; Edward F Bell; Waldemar A Carlo; Seetha Shankaran; Ronald N Goldberg; Richard A Ehrenkranz; Jon E Tyson; Barbara J Stoll; Jeffrey C Murray Journal: J Perinatol Date: 2018-12-05 Impact factor: 2.521
Authors: Adam L Rothman; Du Tran-Viet; Lejla Vajzovic; Vincent Tai; Neeru Sarin; Sandra Holgado; Kathryn E Gustafson; C Michael Cotten; Sharon F Freedman; Cynthia A Toth Journal: Retina Date: 2015-10 Impact factor: 4.256
Authors: Rolf F Maier; Helmut Hummler; Ulrich Kellner; Tim U Krohne; Burkhard Lawrenz; Birgit Lorenz; Barbara Mitschdörfer; Claudia Roll; Andreas Stahl Journal: Ophthalmologie Date: 2022-05-04
Authors: José Carlos Rivera; Mari Holm; Dordi Austeng; Tora Sund Morken; Tianwei Ellen Zhou; Alexandra Beaudry-Richard; Estefania Marin Sierra; Olaf Dammann; Sylvain Chemtob Journal: J Neuroinflammation Date: 2017-08-22 Impact factor: 8.322
Authors: Rolf F Maier; Helmut Hummler; Ulrich Kellner; Tim U Krohne; Burkhard Lawrenz; Birgit Lorenz; Barbara Mitschdörfer; Claudia Roll; Andreas Stahl Journal: Ophthalmologe Date: 2021-03-10 Impact factor: 1.059
Authors: Ryan Swan; Sang Jin Kim; J Peter Campbell; R V Paul Chan; Kemal Sonmez; Kent D Taylor; Xiaohui Li; Yii-Der Ida Chen; Jerome I Rotter; Charles Simmons; Michael F Chiang Journal: Ophthalmol Retina Date: 2018-03-08